BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9800258)

  • 1. Pap smear screening in an urban STD clinic. Yield of screening and predictors of abnormalities.
    Shlay JC; McGill WL; Masloboeva HA; Douglas JM
    Sex Transm Dis; 1998 Oct; 25(9):468-75. PubMed ID: 9800258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of genital human papillomavirus infection in a female adolescent population.
    Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
    Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
    Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
    Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up of abnormal Papanicolaou smears in a hospital-based adolescent clinic.
    Lavin C; Goodman E; Perlman S; Kelly LS; Emans SJ
    J Pediatr Adolesc Gynecol; 1997 Aug; 10(3):141-5. PubMed ID: 9288658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C; Austin RM
    Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions.
    Alanen KW; Elit LM; Molinaro PA; McLachlin CM
    Cancer; 1998 Feb; 84(1):5-10. PubMed ID: 9500646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of chlamydia and Pap-smear abnormalities in pregnant adolescents warrants routine screening.
    Quinlivan JA; Petersen RW; Gurrin LC
    Aust N Z J Obstet Gynaecol; 1998 Aug; 38(3):254-7. PubMed ID: 9761147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of 10,296 pediatric and adolescent Papanicolaou smear diagnoses in northern New England.
    Mount SL; Papillo JL
    Pediatrics; 1999 Mar; 103(3):539-45. PubMed ID: 10049953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of abnormal cervical cytology in a sexually transmitted diseases clinic.
    Kanno MB; Nguyen RH; Lee EM; Zenilman JM; Erbelding EJ
    Int J STD AIDS; 2005 Aug; 16(8):549-52. PubMed ID: 16105189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.
    Longatto-Filho A; Maeda MY; Erzen M; Branca M; Roteli-Martins C; Naud P; Derchain SF; Hammes L; Matos J; Gontijo R; Sarian LO; Lima TP; Tatti S; Syrjänen S; Syrjänen K
    Acta Cytol; 2005; 49(5):500-6. PubMed ID: 16334026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colposcopic evaluation after a repeat atypical squamous cells of undetermined significance (ASCUS) smear.
    Gerber S; De Grandi P; Petignat P; Mihaescu A; Delaloye JF
    Int J Gynaecol Obstet; 2001 Dec; 75(3):251-5. PubMed ID: 11728485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative risk of high grade squamous intraepithelial lesion associated with prior abnormal Pap smears.
    Collins LC; Niloff J; Burke L; Abu-Jawdeh G; Wang H
    J Reprod Med; 2001 Feb; 46(2):105-9. PubMed ID: 11255808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
    Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
    Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of histiocyte detection in Pap smears for predicting endometrial pathology. An institutional experience.
    Nassar A; Fleisher SR; Nasuti JF
    Acta Cytol; 2003; 47(5):762-7. PubMed ID: 14526675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Study of Pap Smears in HIV-Positive and HIV-Negative Women from a Tertiary Care Center in South India.
    Gupta K; Philipose CS; Rai S; Ramapuram J; Kaur G; Kini H; Gv C; Adiga D
    Acta Cytol; 2019; 63(1):50-55. PubMed ID: 30721904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is a liquid-based cytology more sensitive than a conventional Pap smear?
    Sigurdsson K
    Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear.
    Pitman MB; Cibas ES; Powers CN; Renshaw AA; Frable WJ
    Cancer; 2002 Jun; 96(3):128-34. PubMed ID: 12115299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
    Budge M; Halford J; Haran M; Mein J; Wright G
    Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between the cervico-vaginal inflammatory cytology and the intraepithelial cervical lesion in patients from a sexual and reproductive health clinic in Bogotá, Colombia, 1999-2003].
    Duarte HG; Romero JA; Schmalbach JE
    Rev Salud Publica (Bogota); 2004; 6(3):253-69. PubMed ID: 15656066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up Papanicolaou smear for cervical atypia: are we missing significant disease? A HARNET Study.
    Slawson DC; Bennett JH; Herman JM
    J Fam Pract; 1993 Mar; 36(3):289-93. PubMed ID: 8454975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.